These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 26915683

  • 1. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma.
    Xue WJ, Feng Y, Wang F, Guo YB, Li P, Wang L, Liu YF, Wang ZW, Yang YM, Mao QS.
    Sci Rep; 2016 Feb 26; 6():22149. PubMed ID: 26915683
    [Abstract] [Full Text] [Related]

  • 2. Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma.
    Liang J, Zhang X, Miao Y, Li J, Gan Y.
    Int J Nanomedicine; 2017 Feb 26; 12():2033-2044. PubMed ID: 28352173
    [Abstract] [Full Text] [Related]

  • 3. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
    Li G, Cao L, Zhou Z, Chen Z, Huang Y, Zhao Y.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():379-388. PubMed ID: 25779605
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor.
    Sun R, Fang L, Lv X, Fang J, Wang Y, Chen D, Wang L, Chen J, Qi Y, Tang Z, Zhang J, Tian Y.
    Drug Deliv; 2021 Dec 01; 28(1):2071-2084. PubMed ID: 34595970
    [Abstract] [Full Text] [Related]

  • 5. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D, Chang R, Wang G, Hu B, Qiang Y, Chen Z.
    Anticancer Agents Med Chem; 2017 Dec 01; 17(7):948-954. PubMed ID: 27671301
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L, Liang L, Guo M, Li M, Yu X, Wang Y, Wang Y.
    Curr Top Med Chem; 2021 Oct 05; 21(14):1268-1284. PubMed ID: 34620053
    [Abstract] [Full Text] [Related]

  • 7. The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity.
    Gu D, Jin H, Jin G, Wang C, Wang N, Hu F, Luo Q, Chu W, Yao M, Qin W.
    Cancer Lett; 2016 Aug 28; 379(1):107-16. PubMed ID: 27241665
    [Abstract] [Full Text] [Related]

  • 8. Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy.
    Yang Z, Duan J, Wang J, Liu Q, Shang R, Yang X, Lu P, Xia C, Wang L, Dou K.
    Int J Nanomedicine; 2018 Aug 28; 13():1851-1865. PubMed ID: 29618926
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
    Xiong M, Li Y, He H, Hao S, Fang P, Xu M, Chen Y, Chen Y, Yu S, Hu H.
    Eur J Pharm Biopharm; 2023 Aug 28; 189():152-164. PubMed ID: 37336365
    [Abstract] [Full Text] [Related]

  • 10. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.
    Zhu XL, Du YZ, Yu RS, Liu P, Shi D, Chen Y, Wang Y, Huang FF.
    Int J Mol Sci; 2013 Jul 29; 14(8):15755-66. PubMed ID: 23899789
    [Abstract] [Full Text] [Related]

  • 11. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice.
    Varshney A, Panda JJ, Singh AK, Yadav N, Bihari C, Biswas S, Sarin SK, Chauhan VS.
    Hepatology; 2018 Apr 29; 67(4):1392-1407. PubMed ID: 29108133
    [Abstract] [Full Text] [Related]

  • 12. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L, Tang C, Yin C.
    Biomaterials; 2014 May 29; 35(15):4589-600. PubMed ID: 24613049
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 3-O-β-D-galactosylated resveratrol-loaded polydopamine nanoparticles for hepatocellular carcinoma treatment.
    Shan X, Lv S, Cheng H, Zhou L, Gao Y, Xing C, Li D, Tao W, Zhang C.
    Eur J Pharm Biopharm; 2024 Oct 29; 203():114454. PubMed ID: 39142541
    [Abstract] [Full Text] [Related]

  • 14. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep 29; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 15. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
    Huang KW, Lai YT, Chern GJ, Huang SF, Tsai CL, Sung YC, Chiang CC, Hwang PB, Ho TL, Huang RL, Shiue TY, Chen Y, Wang SK.
    Biomacromolecules; 2018 Jun 11; 19(6):2330-2339. PubMed ID: 29808997
    [Abstract] [Full Text] [Related]

  • 16. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver.
    Morimoto K, Nishikawa M, Kawakami S, Nakano T, Hattori Y, Fumoto S, Yamashita F, Hashida M.
    Mol Ther; 2003 Feb 11; 7(2):254-61. PubMed ID: 12597914
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe3O4 composite as a novel nanoscale molecular probe for early diagnosis and therapy in hepatocellular carcinoma.
    Shen JM, Li XX, Fan LL, Zhou X, Han JM, Jia MK, Wu LF, Zhang XX, Chen J.
    Int J Nanomedicine; 2017 Feb 11; 12():1183-1200. PubMed ID: 28243083
    [Abstract] [Full Text] [Related]

  • 18. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An in vitro and in vivo Study.
    Xu YH, Yang J, Meng J, Wang H.
    Chin Med Sci J; 2020 Jun 30; 35(2):142-150. PubMed ID: 32684234
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
    Liu F, Feng L, Zhang L, Zhang X, Zhang N.
    Int J Pharm; 2013 Jul 15; 451(1-2):41-9. PubMed ID: 23608199
    [Abstract] [Full Text] [Related]

  • 20. Complex of TNF-α and Modified Fe3O4 Nanoparticles Suppresses Tumor Growth by Magnetic Induction Hyperthermia.
    Teo P, Wang X, Chen B, Zhang H, Yang X, Huang Y, Tang J.
    Cancer Biother Radiopharm; 2017 Dec 15; 32(10):379-386. PubMed ID: 29265918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.